期刊文献+

急性缺血性卒中动脉再通治疗 被引量:1

Intra-arterial recanalization for acute ischemic stroke
原文传递
导出
摘要 动脉再通治疗可快速恢复血流并挽救缺血半暗带组织,已成为急性缺血性卒中最有效的治疗手段.许多新的血管再通方法已应用于临床.文章对该领域的研究进展进行了综述. Intra-arterial recanalization may rapidly restore blood flow and salvage the ischemie penumbra, which has become the most effective therapeutic means for acute ischemic stroke. Many novel revascularization therapies have been used in clinical practice, This article reviews the advances in this field.
作者 张毅 滕皋军
出处 《国际脑血管病杂志》 北大核心 2010年第5期342-346,共5页 International Journal of Cerebrovascular Diseases
关键词 卒中 脑缺血 脑血管重建术 血栓溶解疗法 纤维蛋白溶解药 血栓切除术 再灌注损伤 Stroke Brain ischemia Cerebral revascularization Thrombolytic therapy Fibrinolytic agents Thrombectomy Reperfusion injury
  • 相关文献

参考文献42

  • 1Lopez AD,Mathers CD,Ezzati M,et al.Global and regional burden of disease and risk factors,2001:systematic analysis of population health data.Lancet,2006,367:1747-1757.
  • 2Prospective Studies Collaboration; Lewington S,Whitlock G,Clarke R,et al.Blood cholesterol and vascular mortality by age,sex,and blood pressure:a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.Lancet,2007,370:1829-1839.
  • 3Stoll G,Bendszus M.Inflammation and atherosclerosis:novel insights into plaque formation and dostabilizaion.Stroke,2006,37:1923-1932.
  • 4Hughes M,Lip GY; Guideline Development Group,National Clinical Guideline for Mjanagement of Atrial Fibrillation in Primary and Secondary Care,National Institute for Health and Clinical Excellence.Stroke and thromboembolism in atrial fibillation:a systematic review of stroke risk factors,risk stratification schema and cost effeetiveness data.Thromb Haemost,2008,99:295-304.
  • 5The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke.N Engl J Med,1995,333:1581-1587.
  • 6Micieli G,Marcheselli S,Tosi PA.Safety and efficacy of alteplase in the treatment of acute ischemic stroke.Vasc Health Risk Manag,2009,5:397409.
  • 7Huber D,Cramer EM,Kaufmann JE,et al.Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palado bodies in human endothelial cells both in vitro and in vivo.Blood,2002,99:3637-3645.
  • 8Kaur J,Zhao Z,Klein GM,et al.The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab,2004,24:945-963.
  • 9Liebman KM,Severson MA 3rd.Techniques and devices in neuro-endovascular procedures.Neurosurg Clin N Am,2009,20:315-340.
  • 10Davydov L,Cheng JW.Tenecteplase:a review.Clin Ther,2001,23:982 -981.

同被引文献18

  • 1Hoffmann O,Zipp F,Weber JR.Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.J Mol Med (Berl),2009,87:753-763.
  • 2Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity,1995,3:673-682.
  • 3Martin-Villalba A,Herr I,Jeremias I,et al.CD95 ligand (Fas-L/ APO-IL) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons.J Neurosci,1999,19:3809-3817.
  • 4Harper N,Hughes M,MacFarlane M,et al.Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factorinduced apoptosis.J Biol Chem,2003,278:25534-25541.
  • 5LeBlanc HN,Ashkenazi A.Apo2L/TRAIL and its death and decoy receptors.Cell Death Differ,2003,10:66-75.
  • 6Schoppet M,Sattler AM,Schaefer JR,et al.Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis.Atherosclerosis,2006,184:446-447.
  • 7Chen PL,Easton AS.Evidence that tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits angiogenesis by inducing vascular endothelial cell apoptosis.Biochem Biophys Res Commun,2010,391:936-941.
  • 8Corallini F,Rimondi E,Secchiero P.TRAIL and osteoprotegerin:a role in endothelial physiopathology? Front Biosci,2008,13:135-147.
  • 9Kruyt FA.TRAIL and cancer therapy.Cancer Lett,2008,263:14-25.
  • 10Cui M,Wang L,Liang X,et al.Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia.Neurobiol Dis,2010,39:138-147.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部